164 related articles for article (PubMed ID: 18984422)
1. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke.
Cucchiara B; Tanne D; Levine SR; Demchuk AM; Kasner S
J Stroke Cerebrovasc Dis; 2008; 17(6):331-3. PubMed ID: 18984422
[TBL] [Abstract][Full Text] [Related]
2. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study.
Saqqur M; Molina CA; Salam A; Siddiqui M; Ribo M; Uchino K; Calleja S; Garami Z; Khan K; Akhtar N; O'Rourke F; Shuaib A; Demchuk AM; Alexandrov AV;
Stroke; 2007 Jan; 38(1):69-74. PubMed ID: 17138949
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.
Cocho D; Borrell M; Martí-Fàbregas J; Montaner J; Castellanos M; Bravo Y; Molina-Porcel L; Belvís R; Díaz-Manera JA; Martínez-Domeño A; Martínez-Lage M; Millán M; Fontcuberta J; Martí-Vilalta JL
Stroke; 2006 Apr; 37(4):996-9. PubMed ID: 16497981
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
Prabhakaran S; Rivolta J; Vieira JR; Rincon F; Stillman J; Marshall RS; Chong JY
Arch Neurol; 2010 May; 67(5):559-63. PubMed ID: 20212195
[TBL] [Abstract][Full Text] [Related]
5. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.
Cucchiara B; Kasner SE; Tanne D; Levine SR; Demchuk A; Messe SR; Sansing L; Lees KR; Lyden P;
Stroke; 2009 Sep; 40(9):3067-72. PubMed ID: 19608993
[TBL] [Abstract][Full Text] [Related]
8. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis.
Lou M; Safdar A; Mehdiratta M; Kumar S; Schlaug G; Caplan L; Searls D; Selim M
Neurology; 2008 Oct; 71(18):1417-23. PubMed ID: 18955684
[TBL] [Abstract][Full Text] [Related]
9. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
11. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
Saposnik G; Demchuk A; Tu JV; Johnston SC;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
[TBL] [Abstract][Full Text] [Related]
12. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator.
Menon BK; Saver JL; Prabhakaran S; Reeves M; Liang L; Olson DM; Peterson ED; Hernandez AF; Fonarow GC; Schwamm LH; Smith EE
Stroke; 2012 Sep; 43(9):2293-9. PubMed ID: 22811458
[TBL] [Abstract][Full Text] [Related]
13. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial.
Kase CS; Furlan AJ; Wechsler LR; Higashida RT; Rowley HA; Hart RG; Molinari GF; Frederick LS; Roberts HC; Gebel JM; Sila CA; Schulz GA; Roberts RS; Gent M
Neurology; 2001 Nov; 57(9):1603-10. PubMed ID: 11706099
[TBL] [Abstract][Full Text] [Related]
14. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J
Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke.
Dharmasaroja PA; Muengtaweepongsa S; Pattaraarchachai J; Dharmasaroja P
J Clin Neurosci; 2012 Jun; 19(6):799-803. PubMed ID: 22472785
[TBL] [Abstract][Full Text] [Related]
16. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy and the risk of intracranial hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke.
Hallevi H; Grotta JC
Arch Neurol; 2008 May; 65(5):575-6. PubMed ID: 18474730
[No Abstract] [Full Text] [Related]
18. Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis.
Sung SF; Chen SC; Lin HJ; Chen YW; Tseng MC; Chen CH
Stroke; 2013 Jun; 44(6):1561-6. PubMed ID: 23632979
[TBL] [Abstract][Full Text] [Related]
19. Thrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage.
Reuter B; Grudzenski S; Chatzikonstantinou E; Meairs S; Ebert A; Heiler P; Schad LR; Staufenbiel M; Hennerici MG; Fatar M
Stroke; 2014 Aug; 45(8):2411-6. PubMed ID: 25005438
[TBL] [Abstract][Full Text] [Related]
20. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature.
Edwards NJ; Kamel H; Josephson SA
Stroke; 2012 Feb; 43(2):412-6. PubMed ID: 22156701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
